These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9589738)

  • 1. Conjunctival vs sublingual administration of carteolol 2% eye drops. Ocular hypotensive effects and some systemic parameter changes.
    Camerino L; Gastaldi C; Brogliatti B; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 1997; (224):52-3. PubMed ID: 9589738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
    Yamamoto T;
    Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension.
    Yamamoto T; Ikegami T; Ishikawa Y; Kikuchi S;
    Am J Ophthalmol; 2016 Nov; 171():35-46. PubMed ID: 27565224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First report of sweating associated with topical beta-blocker therapy.
    Schmutz JL; Barbaud A; Reichert S; Vasse JP; Trechot P
    Dermatology; 1997; 194(2):197-8. PubMed ID: 9094480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Case from general practice. Bradycardic atrial flutter].
    Osterwalder P; Garzoli G; Greminger P
    Praxis (Bern 1994); 1998 Aug; 87(33):1034-6. PubMed ID: 9747135
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
    Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
    Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular hypotensive efficacy and safety of once daily carteolol alginate.
    Demailly P; Allaire C; Trinquand C;
    Br J Ophthalmol; 2001 Aug; 85(8):921-4. PubMed ID: 11466245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical carteolol on retinal arterial blood flow in primary open-angle glaucoma patients.
    Kawai M; Nagaoka T; Takahashi A; Sato E; Yoshida A
    Jpn J Ophthalmol; 2012 Sep; 56(5):458-63. PubMed ID: 22695833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
    Stewart WC; Dubiner HB; Mundorf TK; Laibovitz RA; Sall KN; Katz LJ; Singh K; Shulman DG; Siegel LI; Hudgins AC; Nussbaum L; Apostolaros M
    Am J Ophthalmol; 1999 Feb; 127(2):142-7. PubMed ID: 10030554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration].
    Kawase K; Yamamoto T; Muramatsu T; Ono J; Nakajima T; Matsuhisa A; Sugiura T; Migita M; Ishikawa Y
    Nippon Ganka Gakkai Zasshi; 2010 Nov; 114(11):976-82. PubMed ID: 21141077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients.
    Renard P; Kovalski JL; Cochereau I; Jaulerry S; Williamson W; Elena PP; Lablache Combier M; Allaire C; Siou-Mermet R
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1221-7. PubMed ID: 16003515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol.
    Behrens-Baumann W; Kimmich F; Walt JG; Lue J
    Ophthalmologica; 1994; 208(1):32-6. PubMed ID: 8145982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carteolol: preliminary study on ocular pressure-reducing action.
    Gorgone G; Spina F; Amantia L
    Ophthalmologica; 1983; 187(3):171-3. PubMed ID: 6355953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
    Ishii Y; Nakamura K; Matsuki S; Uemura N; Muraguchi R; Nakagawa M; Nakano S; Nakatsuka K
    J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group.
    Stewart WC; Cohen JS; Netland PA; Weiss H; Nussbaum LL
    Am J Ophthalmol; 1997 Oct; 124(4):498-505. PubMed ID: 9323940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure-reducing efficacy and tolerability of betaxolol in ionic solution.
    Troiano P; Cavallotti B; Iraci M; Galli L; Miglior M
    Acta Ophthalmol Scand Suppl; 1997; (224):18-20. PubMed ID: 9589712
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol.
    Le Jeunne CL; Hugues FC; Dufier JL; Munera Y; Bringer L
    J Clin Pharmacol; 1989 Feb; 29(2):97-101. PubMed ID: 2565918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular tension and pupil diameter effects of timolol 0.50% and pilocarpine 2% or 4% in association.
    Taverniti L; Voccia L; Amoroso L; De Stefano C; Virno M
    Acta Ophthalmol Scand Suppl; 1997; (224):55-6. PubMed ID: 9589741
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
    Schnarr KD
    Klin Monbl Augenheilkd; 1988 Feb; 192(2):167-72. PubMed ID: 2896266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.